2021 annual financial data
Aytu BioPharma 2021 Operating margin
Direct answer
Operating margin was -89.7%.
Operating income was -58,870,000 USD and net income was -58,289,000 USD.
Operating cash flow was -25,964,000 USD.
Get free Aytu BioPharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 65,632,000 USD
- Operating income
- -58,870,000 USD
- Net income
- -58,289,000 USD
- Operating cash flow
- -25,964,000 USD